A unique development company for NALIA array technology
NALIA was founded to develop and commercialise the NALIA array technology with broad applications in research, biomarker validation and point-of-care diagnosis and monitoring.
NALIA's technology provides arrays of multiple biomarkers in either a standard 96-well format or in a single-sample point-of-care format.
Each NALIA Array will replace several existing single biomarker assays and extend the scope of information available, which will enable clinicians to improve the diagnosis of complex diseases without increasing healthcare costs.
Customised or bespoke panels of biomarkers or “NALIA Arrays” are provided in an industry-standard multiwell format for use in biomedical research and clinical laboratories.